Gossamer Bio Stock Short Ratio
| GOSS Stock | USD 0.66 0.04 5.71% |
Gossamer Bio fundamentals help investors to digest information that contributes to Gossamer Bio's financial success or failures. It also enables traders to predict the movement of Gossamer Stock. The fundamental analysis module provides a way to measure Gossamer Bio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Gossamer Bio stock.
Gossamer |
Gossamer Bio Company Short Ratio Analysis
Gossamer Bio's Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
Current Gossamer Bio Short Ratio | 8.17 X |
Most of Gossamer Bio's fundamental indicators, such as Short Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Gossamer Bio is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
| Competition |
Based on the latest financial disclosure, Gossamer Bio has a Short Ratio of 8.17 times. This is 109.49% higher than that of the Biotechnology sector and 10.26% higher than that of the Health Care industry. The short ratio for all United States stocks is 104.25% lower than that of the firm.
Gossamer Short Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Gossamer Bio's direct or indirect competition against its Short Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Gossamer Bio could also be used in its relative valuation, which is a method of valuing Gossamer Bio by comparing valuation metrics of similar companies.Gossamer Bio is currently under evaluation in short ratio category among its peers.
Gossamer Fundamentals
| Return On Equity | -0.9 | ||||
| Return On Asset | -0.11 | ||||
| Profit Margin | (0.68) % | ||||
| Operating Margin | (3.58) % | ||||
| Current Valuation | 34.42 M | ||||
| Shares Outstanding | 226.6 M | ||||
| Shares Owned By Insiders | 2.94 % | ||||
| Shares Owned By Institutions | 77.47 % | ||||
| Number Of Shares Shorted | 6.3 M | ||||
| Price To Earning | (4.61) X | ||||
| Price To Book | 2.92 X | ||||
| Price To Sales | 1.54 X | ||||
| EBITDA | (172.15 M) | ||||
| Net Income | (179.82 M) | ||||
| Cash And Equivalents | 304.38 M | ||||
| Cash Per Share | 3.29 X | ||||
| Total Debt | 212.46 M | ||||
| Debt To Equity | 3.86 % | ||||
| Current Ratio | 5.93 X | ||||
| Book Value Per Share | 0.24 X | ||||
| Cash Flow From Operations | (159.16 M) | ||||
| Short Ratio | 8.17 X | ||||
| Earnings Per Share | (0.24) X | ||||
| Price To Earnings To Growth | (0.63) X | ||||
| Target Price | 6.72 | ||||
| Number Of Employees | 135 | ||||
| Beta | 1.96 | ||||
| Market Capitalization | 161.98 M | ||||
| Total Asset | 311.92 M | ||||
| Retained Earnings | (1.21 B) | ||||
| Working Capital | 254.92 M | ||||
| Current Asset | 441.63 M | ||||
| Current Liabilities | 39.84 M | ||||
| Net Asset | 311.92 M |
About Gossamer Bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Gossamer Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Gossamer Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Gossamer Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Gossamer Stock Analysis
When running Gossamer Bio's price analysis, check to measure Gossamer Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gossamer Bio is operating at the current time. Most of Gossamer Bio's value examination focuses on studying past and present price action to predict the probability of Gossamer Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gossamer Bio's price. Additionally, you may evaluate how the addition of Gossamer Bio to your portfolios can decrease your overall portfolio volatility.